Jones Financial Companies Lllp Buys 1,228 Shares of Revvity, Inc. (NYSE:RVTY)

Jones Financial Companies Lllp raised its holdings in shares of Revvity, Inc. (NYSE:RVTY) by 39.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,312 shares of the company’s stock after buying an additional 1,228 shares during the period. Jones Financial Companies Lllp’s holdings in Revvity were worth $481,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of RVTY. Metis Global Partners LLC raised its holdings in shares of Revvity by 3.2% in the fourth quarter. Metis Global Partners LLC now owns 8,079 shares of the company’s stock valued at $902,000 after acquiring an additional 254 shares in the last quarter. Fisher Asset Management LLC raised its position in Revvity by 41.0% during the 4th quarter. Fisher Asset Management LLC now owns 57,248 shares of the company’s stock worth $6,389,000 after buying an additional 16,633 shares during the last quarter. Versor Investments LP purchased a new stake in Revvity in the fourth quarter valued at $482,000. Proficio Capital Partners LLC boosted its position in Revvity by 12,298.3% in the 4th quarter. Proficio Capital Partners LLC now owns 195,769 shares of the company’s stock worth $21,850,000 after purchasing an additional 194,190 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Revvity by 7.7% in the fourth quarter. Bank of New York Mellon Corp now owns 826,110 shares of the company’s stock worth $92,202,000 after acquiring an additional 58,876 shares during the period. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Analysts Set New Price Targets

RVTY has been the subject of a number of research reports. Bank of America raised shares of Revvity from a “neutral” rating to a “buy” rating and set a $138.00 target price for the company in a research note on Friday, December 13th. Barclays increased their price target on Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Raymond James restated an “outperform” rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a research report on Monday, February 3rd. KeyCorp boosted their price objective on Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Finally, Sanford C. Bernstein cut Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price objective for the company. in a research report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $136.25.

Revvity Trading Up 0.7 %

NYSE:RVTY opened at $118.40 on Tuesday. The firm has a market cap of $14.23 billion, a P/E ratio of 53.58, a PEG ratio of 3.82 and a beta of 1.06. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. Revvity, Inc. has a 12-month low of $97.32 and a 12-month high of $129.50. The stock’s 50 day simple moving average is $117.05 and its 200-day simple moving average is $118.20.

Revvity (NYSE:RVTY) last released its earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same period in the prior year, the company earned $1.25 earnings per share. Equities analysts anticipate that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.24%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity’s dividend payout ratio (DPR) is presently 12.67%.

Insider Transactions at Revvity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the sale, the insider now directly owns 33,400 shares of the company’s stock, valued at approximately $4,232,782. This trade represents a 31.23 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Tajinder S. Vohra sold 5,492 shares of the stock in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total transaction of $641,520.52. Following the transaction, the insider now directly owns 19,652 shares in the company, valued at approximately $2,295,550.12. This represents a 21.84 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.60% of the company’s stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.